Tolerability and Immunogenicity Study of FLUVAL P Monovalent Influenza Vaccine in Adults and Elderly Persons.
Phase of Trial: Phase III
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Influenza A virus vaccine-H1N1; Influenza virus vaccine
- Indications Influenza A virus H1N1 subtype; Influenza A virus infections; Influenza B virus infections
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Sponsors Fluart Innovative Vaccines
- 19 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Oct 2011 Actual end date (February 2010) added as reported by ClinicalTrials.gov.
- 16 Dec 2009 Results were published in the Lancet.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History